Vyome Holdings, Inc. Stock Analysis & AI Score
Vyome Holdings, Inc. (HIND) has an ST Score of 41.7 (C), driven by its Forecast (B+) and held back by its Profitability (D). Analysts rate it Hold with a $3.50 price target (+69.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Vyome Holdings, Inc. (HIND) has an ST Score of 41.7 (C), driven by its Forecast (B+) and held back by its Profitability (D). Analysts rate it Hold with a $3.50 price target (+69.9% upside).
- Strongest
- ForecastB+
- Weakest
- ProfitabilityD
All factor grades
- ForecastB+
- GrowthB
- Financial StrengthB-
- MomentumC-
- ValuationD
- ProfitabilityD
- Piotroski3/9
Contact
HIND stock: frequently asked questions
What is HIND's ST Score?
Vyome Holdings, Inc. (HIND) has an ST Score of 41.7 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is HIND a buy, hold, or sell?
Analysts rate HIND a Hold, with a price target of $3.50 (+69.9% vs the current price). Our ST Score grades it C (41.7/100). The ST Score is a data-driven signal, not a recommendation.
What are HIND's factor grades?
Valuation D, Profitability D, Financial Strength B-, Momentum C-, Growth B, Forecast B+.
What is HIND's valuation grade?
Vyome Holdings, Inc. (HIND) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is HIND's growth grade?
Vyome Holdings, Inc. (HIND) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is HIND's profitability grade?
Vyome Holdings, Inc. (HIND) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is HIND's financial strength grade?
Vyome Holdings, Inc. (HIND) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for HIND?
The average analyst price target for Vyome Holdings, Inc. (HIND) is $3.50 from 3 analysts, which is +69.9% versus the recent price of $2.06.
What is HIND's Piotroski score?
Vyome Holdings, Inc. (HIND) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.